OTTAWA, July 31, 2012 /CNW/ - Health Canada is informing Canadians that it is assessing the possibility of an increased risk of cancer with long-term use of the drug calcitonin. Calcitonin is a ...
WEST LAFAYETTE, Ind. – A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients. Purdue University innovators ...
Adjunct Associate Professor, Albany College of Pharmacy/Union University, Albany, New York; Clinical Pharmacy Specialist, Stratten VA Medical Center, Albany, New York To recognize the role of any ...
Calcitonin is a peptide hormone secreted by thyroid C-cells in response to rises in circulating calcium. Its classical role is to inhibit osteoclastic bone resorption, thereby acutely reducing serum ...
Medullary thyroid carcinoma (MTC) in MEN2B syndrome is associated with germline RET mutation. Patients harboring de novo mutations are usually diagnosed at more advanced disease stages. We present a ...
Zacks Investment Research on MSN
VKTX stock jumps on Phase I study initiation for new obesity drug
Shares of Viking Therapeutics VKTX rose about 9% on Wednesday after the company expanded its obesity pipeline by advancing a ...
As a substitute, osteoporosis patients are prescribed salmon calcitonin. It does not fibrillate as rapidly but suffers from low potency and the potential for several adverse side effects. "The ...
A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients. The work is supported by the National Institutes of Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results